Universitat i societat xarxa : Usos d'Internet en el sistema educatiu superior de Catalunya. Informe final de recerca (volum I)

Aquest estudi analitza -seguint una metodologia quantitativa basada en una mostra representativa de 2.093 professors i 23.864 estudiants i refor��ada amb elements qualitatius- la transici�� que es produeix en el sistema universitari p��blic catal�� cap a un model m��s adaptat a les noves necessitats de la societat xarxa. Per a aix��, es posa especial ��mfasi en l'an��lisi dels usos que es fa d'Internet (l'eina clau de la societat xarxa) en el m��n universitari i en les transformacions que es donen o es donaran com a conseq����ncia d'aquests usos.

Universitat i societat xarxa : Usos d'Internet en el sistema educatiu superior de Catalunya. Informe final de recerca (volum II)

Aquest estudi analitza -seguint una metodologia quantitativa basada en una mostra representativa de 2.093 professors i 23.864 estudiants i refor��ada amb elements qualitatius- la transici�� que es produeix en el sistema universitari p��blic catal�� cap a un model m��s adaptat a les noves necessitats de la societat xarxa. Per a aix��, es posa especial ��mfasi en l'an��lisi dels usos que es fa d'Internet (l'eina clau de la societat xarxa) en el m��n universitari i en les transformacions que es donen o es donaran com a conseq����ncia d'aquests usos.

Indicateurs de r��sultats du Promedro III, situation en 2008 : rapport final

[Table des mati��res] 1. Introduction. 1.1. Rappel du mandat. 1.2. M��thode. 2. R��sultats. 2.1. Indicateurs du nombre de consommateurs. 2.2. Indicateurs des probl��mes en relation (ou non) avec les drogues chez les jeunes. 2.3. Indicateurs en relation avec la consommation probl��matique de drogues dures en g��n��ral. 2.4. Indicateurs des cons��quences n��gatives pour les usagers de drogues ill��gales. 2.5. Indicateurs des cons��quences n��gatives pour la soci��t��. 3. Annexe.

Cuestiones controvertidas en evaluaci��n econ��mica (III). Intervenciones sanitarias en tres situaciones especiales: enfermedades raras, tratamientos al final de la vida y externalidades en las evaluaciones.

The development of the economic evaluation of health care interventions has become a support tool in making decisions on pricing and reimbursement of new health interventions. The increasingly extensive application of these techniques has led to the identification of particular situations in which, for various reasons, it may be reasonable to take into account special considerations when applying the general principles of economic evaluation. In this article, which closes a series of three, we will discuss, using the Metaplan technique, about the economic evaluation of health interventions in special situations such as rare diseases and end of life treatments, as well as consideration of externalities in assessments, finally pointing out some research areas to solve the main problems identified in these fields.

Treball Final de Master - Servidor de Comunicacions Unificades

L'objectiu d'aquest projecte ��s la creaci�� d'una prova de concepte de comunicacions unificades utilitzant productes de programari lliure existents. Aquesta prova de concepte servir�� per poder fer demostracions del funcionament general del programari implicat amb el m��nim de preparacions, instal��lacions i configuracions pr��vies possibles. El projecte es dividir�� en dos appliances o LiveCD, creats a traves de Suse Studio, anomenats Comunicacions Unificades i Comunicacions Unificades 2.Els productes de programari lliure que composen el Servidor de Comunicacions Unificades els podem classificar en productes principals, plugins o addons dels productes i productes secundaris.Com a productes principals tenim els seg��ents servidors que cobreixen les necessitats principals del Servidor de Comunicacions Unificades:Asterisk v1.8.3 : Servidor de telefonia amb veu sobre IP (VoIP).FreePBX v2.9.0beta2 : GUI de control i administraci�� d'Asterisk.Openfire v3.7.0 : Servidor de IM basat en el protocol XMPP.BigBlueButton v0.71a : Sistema de confer��ncia web. Pendent finalitzar-ne l'implementaci��.I els seguents productes principals que cobreixen les necessitats del servidor de Comunicacions Unificades 2:Zimbra v7.0.1 : Servidor de correu electr��nic i de calendari. Pendent resoldre conflicte inicialitzaci�� LDAP.Funambol v9.0.0 : Sincronitzaci�� Zimbra amb m��bils.Com a plugins o addons del productes tenim, classificats segons el producte:Asterisk addons: chan_jingle i chan_gtalkZimlets: Asterisk, Google Translator, Funambol i SocialsOpenfire pugins: Asterisk, Facebook i GmailCom a productes secundaris tenim els clients necessaris per poder utilitzar l'appliance:Firefox: Navegador web que servir�� com a interf��cie d'usuari per les diferents eines d'administraci�� i la demostraci��.Pigdin o Spark: Clients de missatgeria instant��nia, per l'appliance Comunicacions Unificades.A m��s d'instal��lar aquests productes, s'implementa una interf��cie web, mitjan��ant Drupal, en format HTML per enlla��ar les diferents eines d'administraci�� dels productes, per a cadascun dels dos appliances i es realitzara un Kiosk appliance per a familiaritzar-se amb l'entorn SuseStudio.

Salvage Regimen With Autologous Stem Cell Transplantation With Or Without Rituximab Maintenance For Relapsed Diffuse Large B-Cell Lymphoma (Dlbcl): Coral Final Report

Times Cited: 0 References: 0 Citation MapAbstract : Background: Chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard treatment for relapsed DLBCL. No study has compared salvage therapies and evaluated maintenance post ASCT.Methods: DLBCL CD 20+ in first relapse or pts refractory after first therapy were randomized between R ICE (rituximab, ifosfamide, etoposide, carboplatinum) or R DHAP (rituximab dexamethasone cytarabine cisplatinum). Responding patients received BEAM and ASCT then randomized between observation or maintenance with rituximab every 2 m for 1 yr (Gisselbrecht J Clin Oncol; 2010).Results: Analysis was made on 477 pts (R ICE: 243 pts; R DHAP: 234 pts): 255 relapses >12m, 213 refractory/early relapses; 306 pts had prior rituximab; secondary(s) IPI 0-1: 281 pts; s IPI 2-3:181pts. There was no difference in response rate between R ICE 63.6% and R DHAP 64.3%. There was no difference between R ICE and R DHAP at 4 yrs for EFS (26% vs 37% p=0.2) and OS (43% vs 51%, p=0.3). Factors affecting 4 yrs EFS, PFS and OS were: prior treatment with rituximab; early relapse< 12 m; s IPI 2-3. ASCT was performed in 255 pts and 242 randomized for maintenance: 122 pts rituximab (R), 120 pts observation (O). Distribution between R/O arms were respectively: median age 54 /53 yrs, Male 76/83; female 46/37; secondary IPI 0-1: 84/81; sIPI 2-3: 36/36. 89/76 relapses >12m., 33/41 refractory/early relapses. Median follow up was 44 m with 111 events. 4 yrs EFS was 52.8 % (CI 46-59) with 63% (CI 56-69) OS. There was no difference in EFS, PFS and OS between R and O arms. In multivariate analysis, sIPI2-3 significantly affected EFS, PFS, OS (p=0.0004). Women (83pts) had a better 4 yrs EFS 63% than male (159pts) 37% (p=0.01). The difference was only in the R arm (p=0.004). Gender was an independent prognostic factor in the R arm. Toxicity was mild with 12% SAE versus 4% for R /O respectively.Conclusions: There was no difference between R ICE and R DHAP and between post ASCT maintenance with R or O. Women did significantly better after ASCT with rituximab. Early relapses to upfront rituximab-based chemotherapy have a poor prognosis.

Administra����o de medicamentos: orienta����o final de enfermagem para a alta hospitalar

Este estudo avaliou a orienta����o final de enfermagem para a alta hospitalar quanto �� terap��utica medicamentosa em uma cl��nica de interna����o hospitalar. A amostra constou de 38 pacientes com alta hospitalar em dezembro de 2001 e fevereiro de 2002 e dos enfermeiros que os orientaram. Para coleta dos dados utilizou-se a t��cnica de observa����o n��o participante. Obtivemos como resultados: locais inadequados para orienta����o, poucas informa����es por escrito, curto tempo para orienta����o e n��o utiliza����o de estrat��gias que confirmem o entendimento do paciente quanto as orienta����es. Conclui-se que estes aspectos possam estar contribuindo para ocorr��ncia de erros de medica����o no domic��lio, ap��s a alta hospitalar.

Coordination of Transit and School Busing in Iowa, Final Report, December 2003

The 2003 Iowa General Assembly asked the Iowa Department of Transportation (Iowa DOT) to conduct a study of Iowa public policy regarding coordination of public transit services and school transportation. This report describes the efficiencies that may be obtained by coordinating transit management and maintenance systems in the areas of school transportation, public transit, and other forms of public transportation. The Center for Transportation Research and Education (CTRE) at Iowa State University studied these issues and prepared this report for the Iowa DOT.

El poble d' Ollers i el ve��nat d' Esp��sens, a final dels segle XVIII

Article sobre l' estructura social del poble d' Ollers i el ve��nat d' Esp��sens a finals dels segle XVIII

Final Report on the Polk County Adult Drug Court, 2001

An evaluation has been conducted on the Polk County Drug Court, comparing clients entering the program from its inception through September 30, 1998 with a group of revoked probationers from FY96 (the ���pilot group���) and other offenders referred to drug court who did not enter them program (the ���referred group���).

Final Report on the Polk County Adult Drug Court Executive Summary and Summary of Findings, 2001

An evaluation has been conducted on the Polk County Drug Court, comparing clients entering the program from its inception through September 30, 1998 with a group of revoked probationers from FY96 (the ���pilot group���) and other offenders referred to drug court who did not enter the program (the ���referred group���).

Employment and Wages Covered by Unemployment Insurance, Final County Data, Third Quarter, 2003

Third Quarterly County information for Census of Employment & Wages - County